Published on
September 20, 2022
- 19:54 GMT
FDA Committed to Strengthening U.S. Infant Formula Supply; Review Provides Roadmap to Support Ongoing Efforts
The following is attributed to FDA Commissioner Robert M. Califf, M.D. SILVER SPRING, Md., Sept. 20, 2022 /PRNewswire/ -- For the past several months, the U.S. Food and Drug Administration has been working around the clock with our U.S. government partners …
Distribution channels:
Banking, Finance & Investment Industry
